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Background: Racial disparities in blood pressure control have been well documented in the United States.
Research suggests that many factors contribute to this disparity, including barriers to care at patient, clinician,
healthcare system, and community levels. To date, few interventions aimed at reducing hypertension disparities
have addressed factors at all of these levels. This paper describes the design of Project ReD CHiP (Reducing
Disparities and Controlling Hypertension in Primary Care), a multi-level system quality improvement project. By
intervening on multiple levels, this project aims to reduce disparities in blood pressure control and improve
guideline concordant hypertension care.
Methods: Using a pragmatic trial design, we are implementing three complementary multi-level interventions
designed to improve blood pressure measurement, provide patient care management services and offer expanded
provider education resources in six primary care clinics in Baltimore, Maryland. We are staggering the introduction
of the interventions and will use Statistical Process Control (SPC) charting to determine if there are changes in
outcomes at each clinic after implementation of each intervention. The main hypothesis is that each intervention
will have an additive effect on improvements in guideline concordant care and reductions in hypertension
disparities, but the combination of all three interventions will result in the greatest impact, followed by blood
pressure measurement with care management support, blood pressure measurement with provider education, and
blood pressure measurement only. This study also examines how organizational functioning and cultural
competence affect the success of the interventions.
Discussion: As a quality improvement project, Project ReD CHiP employs a novel study design that specifically
targets multi-level factors known to contribute to hypertension disparities. To facilitate its implementation and
improve its sustainability, we have incorporated stakeholder input and tailored components of the interventions to
meet the specific needs of the involved clinics and communities. Results from this study will provide knowledge
about how integrated multi-level interventions can improve hypertension care and reduce disparities.
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Critical health disparities exist between African Americans
and their white counterparts in the United States. Car-
diovascular disease accounts for more than one-third
of the differences in life expectancy between African
Americans and whites [1]. This disparity is largely
attributed to hypertension and poor blood pressure
control [1,2]. In population-based surveys, African
Americans compared to non-Hispanic whites are more
likely to have hypertension, are treated less often, and
have lower rates of blood pressure control when
treated [3,4].
The pursuit of remedies for these disparities between
African Americans and whites has uncovered multi-
factorial sources of the problem, including barriers to
access, adherence and guideline compliance at the
patient, provider, healthcare system, and community
levels. The fundamental questions of which factors to
address and how to address them are difficult to an-
swer. Although interventions to date may address one
or another source of disparities [5-7], few if any have
intervened on multiple actors in the system: patients,
clinicians, healthcare organizations and communities.
Further, even successful interventions to reduce dispar-
ities may not be sustained past the end of the research
funding. Interventions may ultimately fail when: the
intervention was not adapted well to the organization
where it was implemented; clinicians did not endorse
the intervention; patients and their families were not
actively engaged; or the communities where patients
live posed so many challenges that patients could not
maintain adherence to the intervention over time. In-
terventions are more likely to be sustained if they can
answer such questions as: Do the patients, families, and
clinicians understand the intervention? Is it relevant to
what they care about? Does it address the adherence
barriers they face? Does the intervention fit the local
organization where it is being implemented?
The impracticality of standardizing every aspect of
healthcare delivery makes the classic randomized con-
trolled trial challenging to conduct in real world set-
tings. Thus, we applied a pragmatic trial design to test
whether racial disparities in blood pressure can be
improved in six community practices in Baltimore,
Maryland. Using this pragmatic approach with con-
cepts from Community-Based Participatory Research
[8], we seek to show effectiveness in uncontrolled,
routine clinical care [9]. This project realizes the im-
portance of adapting the intervention to specific char-
acteristics of the clinic sites, taking into account
clinician attitudes about the intervention, directly ad-
dressing patient adherence barriers, and engaging the
community to make the intervention more sustainable
when the research study is over.Methods
Study design and specific aims
Specific aims
This ongoing study has three specific aims, which are
reflected in Table 1 with associated hypotheses and pri-
mary outcome measures. First, we are implementing a
multi-level system quality improvement intervention to
reduce racial disparities in blood pressure control via
three multi-level interventions designed to standardize
the measurement of blood pressure, provide patient care
management services, and offer expanded provider edu-
cation resources.
Second, we aim to determine the association of orga-
nizational functioning and cultural competence at the
clinic level (as perceived by providers and staff ) with im-
provements in guideline concordant hypertension care
and reductions in racial disparities in hypertension.
Third, we seek to examine the relationship of organi-
zational functioning and cultural competence with im-
plementation success and effectiveness of each of the
interventions. During the course of this project we will
also examine the relationship of the interventions with
improvements in patient level factors such as knowledge,
attitudes, experience, activation levels, and medication
adherence.
While we expect that each intervention will increase
guideline-concordant hypertension care, we hypothesize
that the combination of all three interventions will result
in the greatest improvement in hypertension care and
the largest reduction in racial disparities in blood pres-
sure control. We further hypothesize that organizational
functioning and cultural competence will be associated
with guideline-concordant care and smaller racial dispar-
ities at baseline, and that higher scores on these orga-
nizational characteristics will be associated with more
effective interventions, improvements in patient out-
comes, and reductions in disparities over time.
Project ReD CHiP (Reducing Disparities and Control-
ling Hypertension in Primary Care) is one of three re-
search projects in the Johns Hopkins Center to Eliminate
Cardiovascular Health Disparities, which is one of 10
NIH-funded Centers for Population Health and Health
Disparities (CPHHD) [10]. The conceptual model we used
to design Project ReD CHiP recognizes that its implemen-
tation and outcomes are influenced not only by the three
interventions but also by patient, provider, organizational
and community factors (Figure 1). This model is adapted
from the works of Shediac-Ritzkallah and Bone [11],
Simpson [12], and Damschroder et al. [13]. In addition to
using a multi-method approach to address these factors, a
Community and Provider Advisory Board formed of local
stakeholders including political leaders, healthcare pro-
viders, patients, faith community representatives, and
individuals from various community organizations has
Table 1 Project ReD CHiP’s specific aims, hypotheses and main outcome measures
Specific aims Hypotheses Process and outcome measures
To perform a multi-method, staged quality improvement intervention
(better blood pressure measurement, patient care management and
provider education) to increase guideline concordant hypertension
care and to reduce racial disparities in blood pressure control.
• Better blood pressure measurement and better blood pressure
data will lead to less clinical inertia and, ultimately, better blood
pressure control and less racial disparities.
• % of patients with controlled BP and % of
patients with uncontrolled BP with
medication titration in the last 3 months
• Each intervention will have an additive effect and the use of all three
interventions will result in a higher percentage of patients receiving
guideline-concordant hypertension care and a greater reduction in
racial disparities than any single combination or any combination
of two interventions.
• % of patients with controlled BP and
racial disparity in controlled BP
• The care management intervention will have greater net improvement
in blood pressure control at the clinic level than the provider education
intervention. The provider education will have an additive and greater
effect when implemented after the care management intervention than
when employed without the care management intervention.
• % of patients with controlled BP
and racial disparity in controlled BP
To determine the association of organizational functioning and
organizational cultural competence with guideline concordant
hypertension care and racial disparities in blood pressure control.
• Clinics will reflect their local surroundings and clinics with a higher
percentage of minority persons will have lower organizational functioning.
• % of patients with BP control, stratified
by race, compared across clinics
• Clinics with greater organizational cultural competence will have
greater guideline concordant hypertension care and less racial
disparities in blood pressure control.
• Degree of racial disparity
To determine the association between organizational functioning and
organizational cultural competence at the clinic and system level with
the implementation and success of the quality improvement interventions.
• Clinics with higher organizational functioning will have a higher rate
of implementation and more blood pressure control and reduction in
racial disparities than clinics with lower organizational functioning.
• Degree of implementation for each
of the interventions
• Clinics with greater organizational cultural competence will have a higher
rate of implementation and more blood pressure control and reduction in
racial disparities than clinics with less cultural competence.
• Degree of implementation for each
of the interventions
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Figure 1 Project ReD CHiP’s conceptual model.
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CHiP was approved by the Johns Hopkins Institutional
Review Board, protocol number 00037622.Study populations and settings
We are implementing Project ReD CHiP from 2010 to
2015 in six Johns Hopkins Community Physician (JHCP)
primary care practices in the Baltimore, Maryland
metropolitan region (Table 2). JHCP is a network of over
35 primary care and specialty practices serving the state of
Maryland and greater Washington, D.C. region. JHCP has
a tradition of innovation in health services delivery and
has more than 1,000 employees and 370 physicians pro-
viding care for more than 230,000 patients annually. The
clinic sites involved in Project ReD CHiP are located in
both Baltimore City and Baltimore County and four of the
practices are located in medically underserved areas. The
six sites were chosen because they are community-based
and serve patients from a variety of socio-demographic
backgrounds. These practices were recruited with support
from JHCP organizational leadership.
The clinic sites involved in Project ReD CHiP include
45 internal medicine, family practice and medicine/
pediatric primary care providers (PCPs) that care for
approximately 42,845 patients. Medical assistants (MAs;
n = 50), registered dietitians (RDs; n = 3), and doctors
of pharmacy (PharmDs; n = 4) also have important rolesin this project. While individual PCPs can choose not to
participate in the interventions, patient data from these
providers will be included in the overall clinic measures
as this is a multi-level system quality improvement
intervention.
Interventions
Project ReD CHiP includes three primary interventions:
improvement of blood pressure measurement using an
automated device and a standardized protocol; care man-
agement services provided by embedded PharmDs and
RDs; and provider education, communication training,
and individualized provider audit and feedback (Table 3).
We responded to stakeholder input and also specifically
designed each of the interventions in this multi-method
project to target factors known to contribute to hyperten-
sion disparities. Components of each intervention were
additionally tailored to address disparities at patient, pro-
vider, and clinic levels (Table 4). Each intervention is
discussed in detail below.
During the project’s development phase, physicians,
nurse practitioners and MAs participated in baseline
focus groups to discuss the feasibility and acceptability
of the planned interventions. Research staff also attended
clinic meetings and provider retreats and hosted webinars
and workshops to hear feedback from individuals working
in the clinics. At each site, organizational leaders as well
as senior and practice level administrators completed
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from these activities helped to shape the interventions.
We will conduct follow-up focus groups and semi-
structured interviews at the end of implementation to
help increase the long-term effectiveness and sustain-
ability of the interventions.
Blood pressure measurement
The blood pressure measurement intervention aims to
improve blood pressure control and reduce disparities
by improving the accuracy and reliability of clinical mea-
surements. Previously published studies have shown that
adherence to recommended blood pressure techniques
in clinical practice are suboptimal and that errors in
measurements can influence clinicians’ treatment deci-
sions [14-16]. Additionally, many clinical blood pressure
measurements are associated with terminal digit bias,
the phenomenon where measurements are rounded off,
commonly to zeros [37,38].
In the blood pressure measurement intervention we
provided each PCP/MA team at the clinics with an
automated blood pressure measurement device (Omron
HEM-907XL). This device features programmable set-
tings that only inflate the blood pressure cuff after a
timed, three minute rest period (adjusted from the stan-
dard five minute countdown to accommodate concerns
regarding workflow) and then automatically obtains
three consecutive measurements, each separated by 30Table 2 Description of study clinics
Site A Site B
Clinic Characteristics
Primary care providers, n 9 11
Patients, n 7,755 4,733
AA patients, % 65.6 90.1
White patients, % 28.0 4.4
AA patients with HTN, n 2,940 2,777
AA patients with uncontrolled HTN, % 33.1 38.8
White patients with HTN, n 705 80
White patients with uncontrolled HTN, % 29.2 33.9
Local Characteristics
Medically underserved area+ Yes Yes
Median income (in 2011 $US)* $47,472 $36,652
% Below poverty line* 19.0 21.0
% Employed* 55.5 54.8
% Population AA* 71.7 59.1
% High school grad or equivalent* 81.4 76.9
% Vacant housing units* 16.7 19.6
+ By site address.
* By Zip Code Tabulation Area, American Community Survey, 2007–2011. The zip co
are included.
Abbreviations: AA African American, n number, US United States.seconds. The device displays the mean of the three mea-
surements and the MA records the mean value in the
electronic medical record (EMR). In addition to facili-
tating the use of pre-measurement rest periods and
obtaining sequential measurements, the use of these de-
vices eliminates the terminal digit bias often associated
with manual measurements and provides PCPs with
valid and reliable blood pressure readings for every
patient. As clinical uncertainty is believed to be a sig-
nificant contributor to healthcare disparities [23], the
introduction of automated blood pressure devices en-
sures the standardization of an important healthcare
process, which may reduce clinical uncertainty and vari-
ations in care [30].
At initial rollout, hypertension specialists held educa-
tion sessions at each site to introduce the devices and
provide clinicians and staff with evidence for the import-
ance of accurate blood pressure measurements. Research
team members provided on-going site level support for
15 months as the staff became accustomed to the de-
vices. We placed culturally and linguistically tailored
posters explaining the new procedure for blood pressure
measurement throughout the clinics to promote patient
engagement. To improve sustainability of the interven-
tion, the device maintenance and personnel training re-
sponsibilities are being transferred to the organization’s
quality improvement department and key staff at indi-
vidual clinic sites.Site C Site D Site E Site F
11 5 3 6
14,887 3,681 5,628 6,161
23.3 18.4 17.7 20.2
68.9 77.7 73.3 72.6
1,493 359 331 593
29.7 40.1 40.5 42.8
4,209 1,362 650 1,477
24.3 34.9 37.1 30.6
Yes No Yes No
$58,488 $50,459 $47,472 $99,155
8.9 10.6 18.2 7.8
70.7 60.3 59.0 64.4
19.5 16.9 34.1 27.6
85.6 78.7 78.2 92.7
6.7 10.6 14.5 5.6
des representing the residences of the majority of the patients at each site
Table 3 Features of Project ReD CHiP’s interventions
Intervention* Blood pressure measurement Care management Provider education
Goal • Improve accuracy and reliability of
blood pressure measurement and
reduce clinical uncertainty
• Add RDs and PharmDs to primary care teams to deliver
culturally-sensitive patient education, promote
self-management behaviors and improve access
and team functioning
• Incorporate best practices in physician education by
assessing PCP needs, delivering an interactive program
to provide practical communications skills training and
providing performance data feedback on blood pressure
control among patients stratified by race/ethnicity
Participants
and clinics
• Medical assistants and providers • Eligible patients (SBP ≥ 140 and/or DBP ≥ 90 mmHg)
attending the clinic; providers and clinic staff in
referral process
• Providers
• All six participating JHCP clinics • All six participating JHCP clinics; staggered
roll out between 2012-2015
• All six participating JHCP clinics; staggered roll out
between 2012-2015
Rationale Errors resulting from suboptimal blood
pressure measurements can influence
treatment decisions [14-16]
• Two systematic reviews of quality improvement
strategies for hypertension management show team
change interventions including assignment of some
responsibilities to health professional other than provider
result in largest blood pressure reductions [17,18]
• Participatory decision making style is associated with
higher patient satisfaction, continuity of care,
improved self-care behaviors and greater adherence
to medications [11,19-22]
• Standardizing and improving reliability of
blood pressure measurements may improve
PCP confidence in measures and reduce
clinical inertia for treatment
• Audit and feedback approaches have been
associated with improved quality metrics
• Provides standardized measurement
for other two interventions
Level of
intervention
Patient • Providing posters in check-in and
exam areas that demonstrate
appropriate positioning and
give reasons for new process
• Participating in three care management
sessions, totaling two hours
• Promoting patient engagement indirectly by
enhancing providers’ patient-centered communication
and participatory decision-making skills
• Intervening on lifestyle: exercise, weight loss,
DASH diet, medication adherence
Provider
and staff
• Educating providers and medical assistants
about proper blood pressure measurement
through didactic and skills practice
• Referring eligible patients to care management
team
• Providing audit and feedback via race-stratified
hypertension dashboard and web based video training
targeting communication skills that promote
patient adherence
• Receiving reimbursements for panel review of
eligible hypertension patients
Clinic • Introducing tools to facilitate adherence
to recommended techniques
(e.g., Omron HEM-907XL)
• Embedding RDs and PharmDs in clinics as part
of the provider support team
• Building hypertension dashboard on existing
JHCP provider dashboard
• Redesigning patient intake protocols
(proper patient positioning and
multitasking during Omron use)






• Suggested posters in exam
rooms to explain new process
• Recommended specific educational materials and
suggested changes to language, layout and images
• Provided suggestions to make patient stories more




















Table 3 Features of Project ReD CHiP’s interventions (Continued)
Medical
assistants
• Focus groups informed intervention
development and implementation plan
• Focus groups informed intervention development
and implementation plan
N/A
• Identified and trained Master Trainers
and Super-Users at each clinic to
support adoption of devices
• Disseminated time-saving techniques
developed by medical assistants to all sites
Provider • Focus groups informed intervention
development and implementation plan
• Focus groups informed intervention development
and implementation plan
• Focus groups informed intervention development
and implementation plan
• Directed interviews to assess organizational
culture
• Directed interviews to assess organizational
culture
• Directed interviews to assess organizational
culture
• Identified JHCP provider champion • Identified JHCP provider champion • Identified JHCP provider champion
JHCP
leadership
• Directed interviews to assess organizational
culture
• Directed interviews to assess organizational
culture





N/A • Modified existing care manager job description for RDs
• Subcontract with JHHC to hire and fund study RDs
N/A
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The care management intervention seeks to address
blood pressure management by providing patient
education, promoting self-management behaviors, and
introducing organizational change. Poor adherence to
medications [24], limited access to healthful foods [25],
and poor quality diets [26] contribute to racial dispar-
ities in blood pressure control. The care management
team aims to reduce disparities and achieve guideline
concordant care through the promotion of self-
management skills and medication titration.
Patients with a diagnosis of hypertension (ICD9 codes)
and with their most recent blood pressure ≥140/≥90
mmHg are eligible for care management services. Care
managers (either RDs or PharmDs) review the clinic’s
electronic patient registry, which abstracts data from the
practice’s EMR, to identify eligible patients to outreach
via telephone. Providers in the clinic also refer eligible
patients directly to the care managers for care manage-
ment services. Eligible patients receive three sessions to-
taling 120 minutes with an RD and/or a PharmD
(Figure 2). The RD covers lifestyle behaviors related to
the management of hypertension including the DASH
diet, weight loss, and exercise. The PharmD addresses is-
sues related to medication adherence and titration, if ne-
cessary. Embedding care managers in the clinic allows
for additional patient counseling and enhances pro-
viders’ ability to address patients’ complex needs.
Recognizing the effectiveness of motivational inter-
viewing in promoting health behavior change [31,32],
medication adherence [33], and health outcomes [31-33]
in African Americans, our care managers utilize motiv-
ational interviewing techniques to assess patients’ know-
ledge of hypertension, current self-management practices,
barriers to self-management, and individual preferences in
managing hypertension. Additionally, the care managers
provide education and recommendations specific to pa-
tients’ needs, preferences, and cultural context through the
use of customizable, literacy-sensitive modules about blood
pressure management. The care managers also utilize a
community resource guide to help address the environ-
mental determinants of disparities. Delivery of culturally
and linguistically tailored health information increases the
acceptability of interventions in minority populations [35].
Provider education
The provider education intervention aims to improve
blood pressure control and reduce disparities by deliver-
ing individualized performance feedback and introducing
additional provider-tailored educational resources. It has
been shown that PCPs use less patient-centered commu-
nication in visits with African American patients [27,28],
and patients with low health literacy ask their physicians
fewer questions [29]. In developing this intervention, werecognized that the combination of race stratified per-
formance reports and cultural competency training in-
creases clinician awareness of disparities in care [34] and
thus incorporated these strategies.
Through this intervention providers are given access to
a web-based dashboard that imports clinic measurements
and patient information from the EMR. The dashboard in-
creases providers’ awareness of disparities by identifying
the percentage of their patients achieving guideline-
concordant hypertension control overall as well as among
their African American and white patients.
To advance providers’ patient-centered communication
skills we developed a training website containing a series
of ultra-brief (approximately 30 second) video demonstra-
tions of targeted skills using simulated patient-provider in-
teractions. A pilot study using this approach found that
clinicians reported significant changes in routine use of
demonstrated skills even after less than 15 minutes of ex-
posure to the website [39]. Moreover, in earlier work we
found that providing clinicians with communication skills
training can reduce disparities and improve patient-
reported outcomes and blood pressure control in ethnic
minorities [36]. The videos illustrate a variety of assess-
ment and partnership skill examples to improve the
patient-provider encounter and promote patient adher-
ence. A variety of patient scenarios are presented and the
videos demonstrate methods to help providers address
individual and environmental determinants of disparities.
Prior to viewing the video clips, providers complete a
self-assessment regarding their use of specified communi-
cation behaviors during visits with uncontrolled hyperten-
sive patients. Immediately after viewing the skills videos,
they are asked to complete a short survey regarding their
intention to use the demonstrated communication tech-
niques. Six months after their first use of the website, phy-
sicians are contacted again and asked to report on their
use of specified communication behaviors and encouraged
to return to the website.
Data collection, outcome measures, and statistical
analysis plan
Data collection
Prior to implementation, PCPs and MAs at each clinic
completed a ‘motivation survey’ to assess several areas of
focus relevant to the acceptance and implementation of
the interventions. The areas of focus included respon-
dents’ readiness to change; perception of barriers to
safety/quality and addressing healthcare disparities; per-
ception of workflow and organizational stress; medica-
tion prescription practice; and how respondents felt the
interventions would affect the care they provide to their
patients. To better assess organizational functioning and
examine how perceptions of the organization’s teamwork
and safety culture could influence the interventions, we
Table 4 Multi-level disparities tailoring in Project ReD CHiP’s interventions
Blood pressure measurement Care management Provider education
Disparities Specific
Rationale
• Clinical uncertainty is believed
to be a major contributor to
healthcare disparities [23]
• Racial disparities in blood pressure control are due, in
part, to poorer adherence to medications [24], limited
access to healthful foods [25] and poor quality diets [26]
• PCPs use less patient-centered communication in visits with African
American patients [27,28]; patients with low health literacy ask their
physicians fewer questions about medical care issues [29]
• Standardization of healthcare processes
may reduce clinical uncertainty and
variations in care [30]
• 2Motivational interviewing is effective at promoting
health behavior change [31,32], medication adherence
[33] and health outcomes [31-33] in African Americans
• The combination of cultural competency training and race-
stratified performance reports increases clinician
awareness of racial disparities in care [34]
• Delivery of culturally and linguistically-tailored health
information increases acceptability of interventions
in minority populations [35]
• PCP communication skills training improves patient-reported
outcomes and blood pressure control in ethnic minorities
and poor persons [36]
Disparities
Tailoring
Patient • Poster messages and images reduce
patient anxiety and promote trust
• Educational materials culturally and
linguistically tailored
• Patient scenarios include individual and environmental
determinants of disparities and demonstrate methods
to address them
• Motivational interviewing enhances patient
engagement and addresses individual
determinants of disparities
• Community resource guide addresses
environmental determinants of disparities
Provider and Staff • Re-training videos use local
staff as role models
• Care managers enhance providers’ ability to
address patients’ complex psychosocial needs
by providing additional counseling and support
• Dashboard increases provider awareness of disparities
• Communication skills training enhances provider participatory
skills leading to increased patient trust and engagement
Clinic • Patient posters provide culturally
and linguistically tailored
communication
• Availability of phone contacts and flexible
appointment times enhances access
• Financial incentives reward providers for reviewing
disparities data























CM team sees patients for BP check visit
BP: 140-159/90-99# BP: ≥160/≥100
Routine follow-up 
with MD
Month 1: 60 Min. RD Visit
• HTN Education
• Tailored lifestyle plan
Month 2: 30 Min. RD Visit
• HTN Education
• Tailored lifestyle plan
Month 1: 30 Min. Pharm D Visit
• Review and assess Med history and adherence
• Tailored medication titration plan approved by MD
• Lay groundwork for follow-up RD appointments
Month 3: 30 Min. RD Visit
• HTN Education
• Tailored lifestyle plan
Month 3: 30 Min. Pharm D Visit
• Review and assess Med 
history and adherence
• Tailored medication titration 
plan approved by MD
Month 2: 60 Min. RD Visit
• HTN Education
• Tailored lifestyle plan
Month 3: 30 Min. RD Visit
• HTN Education
• Tailored lifestyle plan
BP: <140/<90?
Yes No
Follow-up with MD 
within 1 month
#-Patients with diabetes or chronic kidney disease would be if BP >130/>80 
Based on RD recommendation/assessment 
Figure 2 Project ReD CHiP’s flowchart for patients in care management.
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the Safety Attitude Questionnaire [40], which JHCP ad-
ministers annually to all providers and staff. These sur-
vey responses have been used to describe the baseline
organizational environment at each of the six clinic sites.
In the care management intervention, after patients
attend three visits with the care managers they will
complete surveys to assess their experiences with the
program. Additionally, at two time points throughout
the study we are conducting a patient survey at two of
the participating clinics. We will anonymously survey
210 hypertensive patients in the waiting room at each of
the selected sites. The responses will help assess the im-
pact of the intervention on patient-reported outcomes,
including patient knowledge, attitudes, experiences of
care, and self-reported behaviors at each site.Outcome and process measures
We are retrospectively extracting a range of process and
outcome measures (already collected by the clinics) from
JHCP’s EMRs (Table 5). We are collecting aggregate data
at the system, clinic and provider levels. Data will be
expressed as an aggregate percentage for a time periodof one week, with the denominator equal to the number
of patients seen in clinic by all PCPs that week and the
numerator equal to the number of patients that achieved
the measure as defined in Table 5. Race/ethnicity, gen-
der, age, and presence of other chronic illnesses (dia-
betes, chronic kidney disease, coronary artery disease)
categories will be extracted and the aggregate data will
be stratified by these categories. Race/ethnicity is self-
reported at the initial clinic visit.
Statistical analysis plan
We will use Statistical Process Control (SPC) charting of
measures over time to determine if there is a change at
the system level after the implementation of the inter-
vention and how long after implementation the change
is evident [41,42]. SPC is a set of statistical methods
based on the theory of variation that can be used to
make sense of any process or outcome measured over
time. Data will be visually inspected in a graphical dis-
play of a p-chart (for displaying proportion per time
period). In this case, the x-axis will be each week of data
collection (total of 24 weeks in the baseline data collec-
tion) and the y-axis will be the percent of patients seen
that week with controlled blood pressure. We will
Table 5 Process and outcome measures used in Project ReD CHiP
Type Measure+ Notes and definitions
Primary process
measure
% with uncontrolled BP with medication
titration in last 3 months
Uncontrolled BP ≥140/≥90 (or ≥130/≥80 if DM or chronic kidney disease);
titration can be dose increase or medication change/addition
Secondary process
measures
% with BP measure in EMR in last
12 months
% with history of pre-HTN with BP measure
in last 12 months
Two clinic BPs ≥120-<140≥80-<90; not on HTN medication
% with HTN with measure in last 6 months Two clinic BP ≥140/≥90 OR use of a HTN medication OR ICD9
diagnosis (401.xx)
% with HTN on a thiazide diuretic
% with HTN and DM on ACE-I or ARB DM defined by ICD9 code 250.xx
% with lipid panel performed in last 5 years* May not be possible as EMR only in all clinics since March 2006
% with BP≥135/≥85 screened for DM in last
5 years*
May not be possible as EMR only in all clinics since March 2006
Implementation uptake
process measures
% with BP measured with OMRON
% of SBP and DBP measures ending in zero
% of eligible patients enrolled in care
management
% completion rate for those enrolled in care
management
Provider behavioral intention related to
assessment and partnership skills
Measured at completion of the website review and at 6 months
post-intervention
Change in provider self-reported use of
assessment and partnership behaviors
Measured before the website review and at 6 months post-intervention
% of providers receiving web training at each
site
Measured at 6 months post-intervention
Provider self-reported use of
HTN dashboard
Measured at 6 months post-intervention
Primary outcome
measure




% with controlled LDL Controlled LDL defined as <130 (or <100 if DM or coronary artery disease)
% with controlled HDL Controlled HDL defined as >50 in women or >40 in men
% with controlled triglycerides Controlled triglycerides defined as <150
% with controlled A1C Controlled A1C defined as <7.0
Mean SBP, DBP, LDL, HDL, triglycerides, A1C
+Data are aggregated in one week intervals at baseline, during and after intervention roll-out for a minimum of 24 weeks.
*These measures will only be performed in clinics that have had the EMR system in place for at least 5 years.
Abbreviations: % percent, BP blood pressure, DM diabetes mellitus, EMR electronic medical record; HTN hypertension, ACE-I angiotensin converting enzyme
inhibitor, ARB angiotensin receptor blocker, SBP systolic blood pressure, DBP diastolic blood pressure, LDL low density lipoprotein, HDL high density lipoprotein,
A1C glycated hemoglobin.
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usual changes in the pattern of data that can be assigned
to a specific cause) using a range of statistically-driven
tests, including: one value outside the control limits; two
of three consecutive values above or below the mean
and more than two standard deviations away from the
mean; eight or more values falling above or below the
mean; or six or more values in a row steadily increasing
or decreasing (that is, showing a trend) [42].
We are also collaborating with health economists at
our institution and other CPHHD centers to design and
conduct a collection of cost-effectiveness analyses fromhealth system, patient and societal perspectives, based
on data from several of the ongoing interventions cur-
rently being studied by the CPHHD. We intend to cap-
ture program, patient and spillover healthcare costs, and
cost offsets. The program perspective will determine the
budgetary impact of implementing the interventions.
Both patient and health system perspectives measure
factors impacting individuals’ ability to adhere to the
protocol. The success of interventions depends, in large
part, on this. Additionally, interventions may have sig-
nificant spillover effects, such as additional costs or cost
offsets, on the healthcare system, which could impact
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the likelihood of broader dissemination.
Trial status
The blood pressure intervention was introduced to all six
clinic sites by September 2011 (Figure 3). In three of the
clinics, the care management intervention starts six to
nine months before the provider education intervention
and in the other three clinics the care management inter-
vention starts six to nine months after the provider edu-
cation intervention. At the time of this writing, care
managers have been embedded in one clinic site and are
beginning to expand their services to two other sites.
Providers at two of the sites have access to the dashboard
and have seen the online communication training videos.
We will continue to stagger the introduction of the care
management and provider education interventions to the
remaining clinics over the next two years.
Discussion
This study aims to reduce racial disparities in blood pres-
sure control and improve guideline concordant hyperten-
sion care by implementing a multi-level system quality
improvement intervention. Because we have applied a
pragmatic trial design, our interventions take place within
existing clinic practices. In this discussion, we describe the
changes we made to the intervention design to meet the
needs of local settings and the lessons we have learned so
far while implementing the projects.
We worked collaboratively with each clinic site as well
as with leaders from the JHCP organization to improve
the design of the interventions. Through focus groups
and directed interviews, we learned about their concernsA: Site A 
B: Site B 
C: Site C 
D: Site D 
E: Site E
F: Site F 
Figure 3 Project ReD CHiP’s anticipated intervention timeline.regarding certain components of the proposed interven-
tions and we made changes to the intervention design
prior to implementation based on their feedback. For ex-
ample, to avoid interference with patient flow, clinic staff
requested that there be at least one blood pressure de-
vice for each PCP. They felt that the care management
services should have cultural and community relevance.
We also learned that physicians preferred the dashboard
to be developed in similar format and delivery to existing
provider dashboards at JHCP. We responded to each of
these suggestions and these changes were incorporated
into the intervention design.
In addition to adapting certain elements of the inter-
vention in direct response to specific clinic needs, it has
also proven important to work with local champions
throughout the implementation process. Prior to intro-
ducing the automated blood pressure devices, we identi-
fied one MA at each site as a ‘super-user’ These MAs
not only encouraged their co-workers to follow the new
protocol for measuring blood pressure, but they also
served as liaisons between the research and clinic staff.
In the care management intervention, we chose to have
PharmDs who were already familiar with the clinical
practices serve as part of the intervention team. They
suggested that a triage system be created that would
allow the patients with the most uncontrolled blood
pressures to see the PharmD first to focus on issues of
medication adherence. Their knowledge of the patient
populations served at each clinic and their established
relationships with clinic staff helped to improve uptake
of the care management intervention.
We introduced the interventions in the context of other
studies and other health system changes that were taking
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opment phase to incorporate site-level feedback, under-
stand the organizational climate, and anticipate barriers to
change, certain site level factors required us to make ad-
justments after initial implementation of the interventions.
For example, in response to challenges with patient re-
cruitment in the care management intervention at the first
clinic, we adjusted our scheduling approach to better meet
patient and provider needs. Instead of identifying patients
only through the electronic patient registry, care managers
also began to utilize direct referrals from providers. In par-
ticular, care managers found it more effective to focus
their efforts on recruiting patients who are already present
in the clinic for other appointments, instead of depending
on reaching patients by phone. Responding to provider
feedback, care managers now hold sessions with patients
immediately before scheduled appointments with their
PCP and also offer evening appointments once a week.
We underestimated the demand for additional site level
support to assist with overcoming workflow and time
management issues after the introduction of the auto-
mated devices in the blood pressure intervention. We also
discovered the need to collect qualitative and quantitative
data to determine if sites were adhering to the established
protocol. Responding to these concerns, research staff
members were able to offer time-saving techniques, moni-
tor adherence to the protocol, and assist with device main-
tenance through weekly visits to each of the clinic sites.
Additionally, we developed instructional videos to ensure
that new clinic staff members are trained in the protocol
for proper use of the automated devices.
Many of our initial challenges involved restrictions
with data access and slow information technology (IT)
development. Our initial approach required clinical data
to be transferred from the practices’ EMR to the re-
search team for further analysis to define eligible pa-
tients and outcome data. With this approach, we had
difficulties obtaining the data we needed in a usable and
timely fashion. In addition, delays in the development of
the dashboard website pushed back the rollout of the
provider education intervention. We eventually moved
to an approach that better utilizes the strengths of the
community-based practice organization, which has an
extensive history of utilizing EMR data to improve clin-
ical quality. The community-based organization became
responsible for more of the data abstraction, leveraging
their experience with the nuances of their system. Part-
nering more extensively with members of the organiza-
tion’s IT department helped to speed the data retrieval
and dashboard development processes. The anticipated
introduction of a new EMR system across the entire
organization in 2013 highlights the importance of continu-
ing to develop these relationships throughout the duration
of the project.Limitations of the study deserve mention. First, it is
not mandatory for physicians to view the communica-
tions skills training sessions or utilize the elements on
the dashboard. This may result in reduced uptake and a
potential dilution of the overall effect of the provider
education intervention. Additionally, the care manage-
ment intervention may not be intensive enough to en-
courage sustained behavior change if patients do not
attend all three sessions. Furthermore, in the blood
pressure measurement intervention, we are making
every attempt to collect high quality data, but are pri-
marily relying on self-reports and qualitative measures
to assess adherence to the blood pressure measurement
protocol. This will limit the precision with which we
can examine adherence. The main limitation for the
organizational assessments is that some of our measures
will only be collected once, so we will not know how
these have changed over the course of the intervention.
However, other organizational measures will be col-
lected multiple times, for both intervention and non-
intervention sites, allowing estimation of change over
time and relative to an unexposed group. Lastly, in a
complex healthcare delivery system, additional system-wide
or practice-based quality improvement efforts may con-
found the results, for example, efforts to meet the ‘mean-
ingful use of EMRs’ metrics may improve health system-
patient communication. Because data will be evaluated on
the system level, other unanticipated factors, in addition to
unique clinic level issues, could limit the study’s ability to
detect changes in our desired outcomes.
In conclusion, Project ReD CHiP is a multi-faceted,
multi-level intervention that targets patients, clinicians,
the healthcare organization, and the community to im-
prove hypertension care and reduce racial disparities in
blood pressure control. We strengthened the project’s
design by tailoring intervention components to meet the
needs of the individual clinics. By incorporating prin-
ciples of community-based participatory research and
through the continual engagement of clinic staff, pro-
viders, and organizational leaders, planning for sustain-
ability has been a priority of the project. We recognize
that its implementation and outcomes are influenced by
a variety of factors and have worked to address these
barriers. Furthermore, employing a pragmatic trial de-
sign and introducing the interventions into uncontrolled,
primary care settings enhances the generalizability of
our results and could encourage other clinics to incorp-
orate our findings into routine care. Project ReD CHiP
will provide knowledge about how integrated multi-level
interventions can reduce disparities in blood pressure
control; how organizational functioning can affect guide-
line concordant hypertension care; and how to design
sustainable quality improvement interventions in
community-based clinical settings.
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